Prostaglandin-E2 enhances EPO-mediated STAT5 transcriptional activity by serine phosphorylation of CREB

Blood

Volumn 100, Issue 2, 2002, Pages 467-473

  Boer, Arjen Kars ^a,b,c   Drayer, A Lyndsay ^a,b,c   Rui, Hallgeir ^a,b,c   Vellenga, Edo ^a,b,c,d  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b CMG Noord Nederland   (Netherlands)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUCLADESINE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; ERYTHROPOIETIN; GENE PRODUCT; ISOBUTYLMETHYLXANTHINE; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN E2; PROTEIN BCL X; PROTEIN P300; RECOMBINANT ERYTHROPOIETIN; SERINE; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA BINDING PROTEIN; MILK PROTEIN; STAT5A PROTEIN, HUMAN; STAT5B PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; BINDING AFFINITY; COLONY FORMATION; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; DNA BINDING; ENZYME INHIBITOR INTERACTION; ENZYME MECHANISM; ERYTHROID CELL; ERYTHROPOIESIS; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; TRANSACTIVATION; TRANSCRIPTION REGULATION; CELL LINE; DRUG EFFECT; DRUG POTENTIATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SECOND MESSENGER;

CELL LINE; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DINOPROSTONE; DNA-BINDING PROTEINS; DRUG SYNERGISM; ERYTHROPOIETIN; HUMANS; MILK PROTEINS; PHOSPHORYLATION; SECOND MESSENGER SYSTEMS; SERINE; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0037098854     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V100.2.467     Document Type: Article

References (45)

1. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor
2. Mast cell growth factor modulates CD36 antigen expression on erythroid progenitors from human bone marrow and peripheral blood associated with ongoing differentiation
3. - sorted bone marrow cells of myelodysplasia patients
4. Early events in erythropoietin-induced signaling
5. Phosphatidylinositol 3-kinase is involved in the protection of primary cultured human erythroid precursor cells from apoptosis
6. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells
7. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue
8. Interleukin-3 signals through multiple isoforms of Stat5
9. Stat5a serine phosphorylation. Serine 779 is constitutively phosphorylated in the mammary gland, and serine 725 phosphorylation influences prolactin-stimulated in vitro DNA binding activity
10. Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells
11. Role of serine phosphorylation of Stat5a in prolactinstimulated β-casein gene expression
12. The suppressors of cytokine signaling (SOCS) proteins: Important feedback inhibitors of cytokine action
13. Stat5 and Sp1 regulate transcription of the cyclin D2 gene in response to IL-2
14. Regulation of the trans-activation potential of STAT5 through its DNA-binding activity and interactions with heterologous transcription factors
15. Growth hormone (GH) induces the formation of protein complexes involving Stat5, Erk2, Shc and serine phosphorylated proteins
16. Extracellular signal-regulated kinase (ERK) interacts with signal transducer and activator of transcription (STAT) 5a
17. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5- mediated suppression of the glucocorticoid response
18. β-andrenergic blockade of prostaglandin E2- and D2-induced erythroid colony formation
19. Prostaglandins activation of erythropoietin production and erythroid progenitor cells
20. In vitro interactions of PGE and cAMP with murine and human erythroid precursors
21. In vivo modulation of myelopoiesis by prostaglandin E2, III: Induction of suppressor cells in marrow and spleen capable of mediating inhibition of CFU-GM proliferation
22. Prostaglandin E2 mediated effects on the synthesis of fetal and adult hemoglobin in blood erythroid bursts
23. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133
24. CREBL: A Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases
25. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line
26. Nuclear protein CBP is a coactivator for the transcription factor CREB
27. Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene
28. A protein kinase inhibitor gene reduces both basal and multihormone-stimulated prolactin gene transcription
29. CBP-induced stimulation of c-Fos activity is abrogated by E1A
30. Magnitude of the CREB-dependent transcriptional response is determined by the strength of the interaction between the kinase-inducible domain of CREB and the KIX domain of CREB-binding protein
31. Establishment and characterization of a new erythropoetin-dependent acute myeloid leukemia cell line, AS-E2
32. Differential binding activity of the transcription factor LIL-Stat in immature and differentiated normal and leukemic myeloid cells
33. Rapid detection of octamer binding proteins with "mini extracts," prepared from a small number of cells
34. Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6
35. Role of regulatory subunits and protein kinase inhibitor (PKI) in determining nuclear localization and activity of the catalytic subunit of protein kinase A
36. Recruitment of CREB binding protein is sufficient for CREB-mediated gene activation
37. Megakaryocyte growth and development factorinduced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors
38. Sustained activation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells
39. Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP
40. Functional association of Nmi with Stat5 and Stat1 in IL-2-and IFNgamma-mediated signaling
41. Eukaryotic transcription: An interlaced network of transcription factors and chromatin-modifying machines
42. Site-specific acetylation by p300 or CREB binding protein regulates erythroid Kruppel-like factor transcriptional activity via its interaction with the SWI-SNF complex
43. Expression level-dependent contribution of glucocorticoid receptor domains for functional interaction with stat5
44. Normal Hematopoiesis in mice requires the CREB- and c-Myb-binding surface of the transcriptional coactivator p300
45. Insulin induction of SOCS-2 and SOCS-3 mRNA expression in C2C12 skeletal muscle cells is mediated by Stat5